Markets:

Overview

News

Currencies

International

Treasuries

Psyence Biomedical Ltd. - Common Shares (NQ:PBM)

8.690 -0.800 (-8.43%)

Streaming Delayed Price Updated: 2:59 PM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Psyence Biomedical Ltd. - Common Shares

< Previous 1 2 3 4 5 6 Next >

Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 21, 2024

Via Benzinga

Nasdaq Down 50 Points; S&P Global Composite PMI Hits 26-Month High ↗

June 21, 2024

Via Benzinga

Topics Stocks

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket ↗

June 21, 2024

Via Benzinga

Why Is Psyence Biomedical (PBM) Stock Up 90% Today? ↗

March 08, 2024

With Psyence Biomedical moving into a Phase 2B trial, the credibility boost for its psychedelics-based drug lifted PBM stock.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 21, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 21, 2024

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 01, 2024

Via Benzinga

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗

April 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 22, 2024

Via Benzinga

Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More ↗

March 20, 2024

Via Benzinga

Topics Economy

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 15, 2024

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 15, 2024

Via Benzinga

Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

March 15, 2024

Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 15, 2024

It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 14, 2024

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 12, 2024

Via Benzinga

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 12, 2024

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 12, 2024

Via Benzinga

Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia ↗

March 11, 2024

Via Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...

Via Benzinga

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket ↗

March 11, 2024

Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 11, 2024

Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning!

Via InvestorPlace

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 08, 2024

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 08, 2024

Via Benzinga

What's Going On With Psyence Biomedical Stock? ↗

March 08, 2024

On Wednesday, Psyence Biomedical announced the approval for its Phase IIb study to examine the use of psilocybin as a treatment for Adjustment Disorder due to a recent cancer diagnosis in the...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.